NetworkNewsBreaks – Panbela Therapeutics Inc. (NASDAQ: PBLA) Reports on $6M Closed Offering
Panbela Therapeutics (NASDAQ: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, has released the pricing of its public offering. The public offering is comprised of 20,100,000 shares of its common stock (or prefunded warrants in lieu thereof); the announcement also reported on the pricing of warrants for the purchase of up to 30,150,000 shares of common stock. The offering closed on Oct. 4, 2022. The purchase price was $0.30 per share and associated public warrant. The announcement outlined key information regarding the public warrants: they will have an exercise price…







